DR. NATHAN LYNN GRAVES M.D. NPI 1184653743

NPI Information

  • NPI: 1184653743
  • Provider Name: DR. NATHAN LYNN GRAVES, M.D.
  • Classification: Urology - 208800000X
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1601 LANCASTER DR STE 170
    GRAPEVINE, TX
    ZIP 76051
  • Phone: (817) 481-7727

Map and Directions

Get Directions

NPI Details

DR. Nathan Lynn Graves, M.D. is an urology in Grapevine, TX with 46 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. Nathan Lynn Graves, M.D. NPI is 1184653743. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE
Graduation Year:1980

The provider's business location address is:

1601 LANCASTER DR STE 170
GRAPEVINE, TX
ZIP 76051-110
Phone: (817) 481-7727
Fax: (817) 329-0077

The NPI 1184653743 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
  • Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
  • Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Analysis for antibody to haemophilus influenza (respiratory bacteria) (HCPCS:86684)
  • Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
  • Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
  • Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
  • Detection test by nucleic acid for mycobacteria tuberculosis (tb bacteria), amplified probe technique (HCPCS:87556)
  • Complete ultrasound scan of pelvis (HCPCS:76856)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Limited ultrasound scan behind abdominal cavity (HCPCS:76775)
  • Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
  • Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
  • Ultrasound scan of pelvic region through rectum (HCPCS:76872)
  • Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
  • Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
  • Detection test by nucleic acid for human papillomavirus (hpv), high-risk types (HCPCS:87624)
  • Electronic assessment of bladder emptying (HCPCS:51741)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings (HCPCS:51784)
  • Dilation of urethra using an endoscope (HCPCS:52281)
  • X-ray of abdomen, 1 view (HCPCS:74018)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Injection, meperidine hydrochloride, per 100 mg (HCPCS:J2175)
  • Other procedure on male genital system (HCPCS:55899)
  • Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
  • Detection test by nucleic acid for trichomonas vaginalis (genital parasite), direct probe technique (HCPCS:87660)
  • Destruction of prostate tissue using microwave induced heat (HCPCS:53850)
  • Shock wave crushing of kidney stones (HCPCS:50590)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Biopsy of prostate gland (HCPCS:55700)
  • Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 7/3/2006 and was last updated on 12/15/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1208800000XUrologyF8131TEXASYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.